Tech Company Financing Transactions
Carmell Therapeutics Funding Round
Carmell Therapeutics, operating out of Pittsburgh, raised $3 million in funding from Harbor Light Capital Partners, BlueTree Allied Angels and Innovation Works.
Transaction Overview
Company Name
Announced On
4/15/2011
Transaction Type
Debt
Venture Equity
Venture Equity
Amount
$3,000,000
Round
Series A
Investors
Proceeds Purpose
The company will use the financing to establish a pilot manufacturing facility and collect data for early clinical validation for the company's first products.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2403 Sidney St. 300
Pittsburgh, PA 15203
USA
Pittsburgh, PA 15203
USA
Phone
Website
Email Address
Overview
Carmell Therapeutics is a biotechnology company focused on the development and commercialization of innovative Plasma-based Bioactive Materials (PBMs). These PBMs contain a concentration of natural regenerative factors that promote healing, reduce complications, and lead to healthcare savings.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Randy Hubbell
Chief Medical Officer
James Hart
VP - Client Services
Janet Vargo
VP - R & D
Stephanie Kladakis
VP - Regulatory Affairs
Toby Silverman
Browse more venture capital transactions:
Prev: 4/15/2011: INVIDI Technologies venture capital transaction
Next: 4/15/2011: Instructure venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs